Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Orthobiologics for the Hip Region: A Narrative Review. PM & R : the journal of injury, function, and rehabilitation McInnis, K. C., Chen, E. T., Finnoff, J. T., Roh, E. Y., Borg Stein, J. 2020

Abstract

Management of hip region disorders is challenging. Orthobiologic treatments including platelet rich plasma (PRP), mesenchymal stem cell, and amniotic injectables have gained popularity as promising treatments despite a lack of robust evidence for their effectiveness. We review rationale and current evidence for orthobiologics for three common hip region conditions: hip osteoarthritis, gluteal tendinopathy, and proximal hamstring tendinopathy. Overall, the current state of evidence is extremely limited for orthobiologic treatments. and predominantly relevant to PRP injections. There is currently a lack of data to support the use of mesenchymal stem cells or amniotic injectables in these conditions of the hip. This article is protected by copyright. All rights reserved.

View details for DOI 10.1002/pmrj.12327

View details for PubMedID 31953917